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Abstract
Background:  Fibromyalgia engulfs patients in a downward, reinforcing cycle of unrestorative
sleep, chronic pain, fatigue, inactivity, and depression. In this study we tested whether a mostly raw
vegetarian diet would significantly improve fibromyalgia symptoms.
Methods:  Thirty people participated in a dietary intervention using a mostly raw, pure vegetarian
diet. The diet consisted of raw fruits, salads, carrot juice, tubers, grain products, nuts, seeds, and a
dehydrated barley grass juice product. Outcomes measured were dietary intake, the fibromyalgia
impact questionnaire (FIQ), SF-36 health survey, a quality of life survey (QOLS), and physical
performance measurements.
Results:  Twenty-six subjects returned dietary surveys at 2 months; 20 subjects returned surveys
at the beginning, end, and at either 2 or 4 months of intervention; 3 subjects were lost to follow-
up. The mean FIQ score (n = 20) was reduced 46% from 51 to 28. Seven of the 8 SF-36 subscales,
bodily pain being the exception, showed significant improvement (n = 20, all P for trend < 0.01).
The QOLS, scaled from 0 to 7, rose from 3.9 initially to 4.9 at 7 months (n = 20, P for trend
0.000001). Significant improvements (n = 18, P < 0.03, paired t-test) were seen in shoulder pain at
rest and after motion, abduction range of motion of shoulder, flexibility, chair test, and 6-minute
walk. 19 of 30 subjects were classified as responders, with significant improvement on all measured
outcomes, compared to no improvement among non-responders. At 7 months responders' SF-36
scores for all scales except bodily pain were no longer statistically different from norms for women
ages 45–54.
Conclusion:  This dietary intervention shows that many fibromyalgia subjects can be helped by a
mostly raw vegetarian diet.
Background
The fibromyalgia syndrome (FMS) is characterized by
wide spread pain in the body, associated with particular
tender points [1,2]. It is often accompanied by unrestor-
ative sleep patterns, fatigue, headaches, irritable bowel
and bladder syndrome, morning stiffness, paresthesias,
anxiety, and depression [2,3]. The prevalence rate is
about 2% in the general population, 3.9% of women ages
20–40 and 5.8% of women ages 40–60 [4], and as high
as 8% in women ages 55–64 [5]. FMS is more prevalent
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in women than men, in about a 3:1 ratio [5]. People who
suffer from FMS have a disability index comparable to
that of patients with rheumatoid arthritis [6] while dis-
ease severity was worse than Sjogren's syndrome [7]. The
natural course of FMS may include some symptomatic
relief [8], but many symptoms remain essentially un-
changed after 7 years of follow up [9].
Treatments for FMS include medications (amitriptyline
and fluoxetine most common), nutritional supplements
(malic acid, s-adenosyl methionine, 5-hydroxytryp-
tophan), and physical therapies (cardiovascular training,
stretching, electroacupuncture), and cognitive-behavior
therapy [reviewed in [10–12]]. FMS patients frequently
use alternative therapies, indicating dissatisfaction, or
ineffectiveness of traditional medical therapy [13].
FMS engulfs patients in a downward spiral of unrestora-
tive sleep, chronic pain, fatigue, inactivity, and depres-
sion. Each symptom reinforces the others, making it
difficult to break out of the cycle. A 3-week vegetarian
diet improved subjective well being in FMS patients,
along with significant reductions in serum peroxides,
plasma fibrinogen, apolipoproteins A and B, and serum
total cholesterol [14]. A "living-foods" vegan diet was
used in a 3-month non-randomized controlled study of
FMS subjects [15]. In the intervention group there were
significant improvements in pain scores, quality of sleep,
morning stiffness, health assessment questionnaire
scores, and general health questionnaire. These studies,
along with anecdotal evidence that we have gathered, in-
dicate that a mostly raw food vegetarian diet is helpful in
breaking the cycle of suffering of FMS patients.
In this study we utilized a pure vegetarian diet composed
mostly of common fruits, vegetables, nuts, tubers, carrot
juice, and dehydrated barley grass juice while tracking
participants' FMS status during a 7-month period of
time.
Methods
Subjects
Subjects were recruited from a local fibromyalgia sup-
port group, by notice of the study in a bi-yearly newslet-
ter, and by word of mouth. An informed consent
document explaining the study and the risks and benefits
of participation was given to each potential subject. Writ-
ten consent was obtained from subjects before participa-
tion. The study was conducted in accord with the ethical
standards of the Helsinki Declaration of 1975 as revised
in 1983.
Subjects were required to have a previous diagnosis of
FMS by a rheumatologist, using the American College of
Rheumatology criteria of at least 11 of 18 tender points
being painful upon palpation. Subjects underwent a
physical examination upon entering the study, including
the tender point survey.
Subjects were encouraged to continue with any medica-
tion for sleep or pain. It was believed that this would al-
low the best comparison between initial and final
conditions, with as few variables changing as possible.
Subjects and their prescribing physicians made all med-
ication decisions. The investigators in this study had no
control of medication usage.
Diet implementation
Subjects were supplied with books published by Hallelu-
jah Acres, Inc. (God's Way to Ultimate Health, Recipes
for Life...from God's Garden, 21 Days to health the Hal-
lelujah diet way) and informational pamphlets. Instruc-
tions were given on what foods to eat (fresh fruits, salads,
raw vegetables, carrot juice, nuts, seeds, whole grain
products, tubers, flax seed oil, extra virgin olive oil) what
foods to avoid (alcohol, caffeine, foods containing re-
fined sugar, corn syrup, refined and/or hydrogenated oil,
refined flour, dairy, eggs, and all meat) and how to pre-
pare freshly extracted carrot juice with the supplied
Champion juicer (Plastaket Mfg. Co. Inc., Lodi, CA). Sub-
jects were given a 2-month supply of dehydrated barley
grass juice powder (Barleygreen) and a blend of laxative
herbs and psyllium seed (Herbal Fiberblend) (AIM In-
ternational, Nampa, ID), with instruction to ask for more
when this supply was finished. Subjects were encouraged
to attend a live motivational presentation of the basis of
the Hallelujah Diet to reorient their thinking about food
and health. A video was available for those subjects that
did not attend the presentation. No regular support
meetings were scheduled for motivational encourage-
ment after this initial presentation, as this might make
the results less applicable to the general population.
Main outcome measures
Physical performance measures, as detailed by Man-
nerkorpi, et al. [16], were collected at the beginning and
end of the study. 12 measures were used. These were
shoulder pain at rest, range of active motion abduction
and flexion, shoulder pain on motion, hand to neck, hand
to scapula, isometric shoulder endurance, neck rotation,
hand grip strength, flexibility of the low back and ham-
strings using the sit-and-reach method, chair test
(number of times a subject could stand up in a minute),
and a six-minute walk. All of these measures were taken
by the same physical therapist (SL). Along with these ob-
jective tests, subjects were asked to report their health
status using the Fibromyalgia Impact Questionnaire
[17], the SF-36 short form health survey [18], and a Qual-
ity of Life Survey [19]. The SF-36 has been widely used to
record how a person perceives his or her own health sta-BMC Complementary and Alternative Medicine 2001, 1:7 http://www.biomedcentral.com/1472-6882/1/7
tus. The quality of life survey queries the subject about 16
different aspects of life with a scale from 0 to 7 for each
question. These questionnaires were self-administered
at 0, 2, 4, and 7 months.
A food frequency questionnaire (FFQ), designed to in-
clude commonly eaten foods while following the Hallelu-
jah Diet, was also self-administered at 2, 4, and 7
months. The FFQ administered at 2 months was ana-
lyzed using The Food Processor, version 7.40 (ESHA Re-
search, Eugene, OR).
Statistics
The FIQ, QOL, and SF-36 surveys were analyzed by re-
peated measures analysis of variance. Differences be-
tween time points were calculated using the Bonferroni
comparison. A subgroup of 20 of the participants was
used that reported in the beginning, end, and either 2 or
4 months into the trial. The physical performance meas-
ures were analyzed by the student's paired t-test. 18 sub-
jects gave initial and final physical performance
measures. A significance level less than 0.05 was consid-
ered statistically significant.
Responders and non-responders were initially distin-
guished using the FIQ score. If a subject reported at least
a 10-point improvement in their initial and final FIQ
score, then that subject was classified as a responder. A
10-point improvement in the FIQ correlated with statis-
tically significant improvements in measures of physical
performance, QOLS scores, and SF-36 scores.
Results
Subjects
30 subjects participated in this study, 28 female, 2 male.
All subjects had been previously diagnosed with fibro-
myalgia by a rheumatologist, but not all subjects current-
ly had 11 or more positive tender points. All subjects had
symptoms which they attributed to FMS.
Compliance of subjects was monitored by self-reported
food intakes on a food frequency questionnaire, and by
requests for more dehydrated barley grass juice. Approx-
imately a two-month supply was initially given to each
subject, with instructions to call and ask for more when
their supply ran out.
20 subjects (15 of whom are classified as responders) re-
turned surveys at the beginning, end, and either 2 or 4
months. Detailed results for the self-reported question-
naires (FIQ, SF-36, QOLS) here are reported for this sub-
group. Response (responder or non-responder) to the
dietary intervention is reported based on all 30 subjects
according to the intention to treat principle. Analysis
shows there were no significant differences in gathered
data between the whole group and this sub-group.
Dietary intake
Food frequency questionnaires were collected from 26
participants. Nutrient intakes, based on the FFQ admin-
istered at 2 months, are reported in Table 1. Diet percent-
ages, on an energy basis, were 24 percent fat, 65 percent
carbohydrate, and 11 percent protein. Participants re-
ported drinking 2–4 240 ml servings of carrot juice daily,
so that the mean intake of beta-carotene was 52 mg/day.
Several participants reported less consumption of carrot
juice at 7 months than at 2 months. The dehydrated bar-
ley grass juice was consumed by all but 2 subjects who re-
ported immediate nausea upon consumption of the
Table 1: Nutrient Intake of Subjects. N = 26.
MACRONUTRIENTS
Calories 1700 ± 490
Protein, g 48 ± 15
Carbohydrate, g 299 ± 83
Fiber, g 45 ± 14
Fat-Total, g 50 ± 24
Cholesterol, mg 35 ± 42
VITAMINS
Vitamin A, RE 10,300 ± 4,200
Thiamin, mg 2.1 ± 0.5
Riboflavin, mg 1.7 ± 0.4
Niacin, mg 16.0 ± 4.7
Vitamin B6, mg 3.6 ± 1.0
Vitamin B 12, µg0 . 6   ± 0.7
Vitamin C, mg 570 ± 210
Vitamin D, µg 0.46 ± 0.47
Vitamin E, α -TE 18.1 ± 7.0
Folate, mg 550 ± 200
MINERALS
Calcium, mg 720 ± 220
Copper, mg 2.4 ± 0.7
Iron, mg 15.8 ± 4.2
Magnesium, mg 460 ± 140
Phosphorus, mg 1090 ± 300
Potassium, mg 6400 ± 1400
Sodium, mg 1800 ± 930
Zinc, mg 8.3 ± 2.3BMC Complementary and Alternative Medicine 2001, 1:7 http://www.biomedcentral.com/1472-6882/1/7
powder. Flax seed oil was consumed by 23 of 26 partici-
pants so that the mean intake of n-3 fatty acids was about
6 g/day. Fresh fruit and salads, based mostly on leaf let-
tuce and dark leafy greens rather than head lettuce, were
consumed daily. The high intakes of fruits and vegetables
resulted in high intakes of fiber, vitamin C, folate, potas-
sium, and magnesium. Animal product consumption
was very low, especially intakes of meat, poultry, and
fish. Intakes were mainly from once weekly to none, re-
sulting in low intakes of fat, cholesterol, vitamins B12
and D, and zinc. Soft drink intake was reported in 11 sub-
jects, demonstrating willingness to report truthfully.
Only 3 subjects reported consuming more than a 340 ml
serving per week.
Physical performance
Eighteen subjects were followed up after completion of
the study (see Table 2). Results are only reported for
these 18 subjects, 13 of whom were classified as respond-
ers, Initial values were very similar to values reported by
Mannerkorpi et al. [16]. Significant improvements (P <
0.03, paired t-test) in these 18 subjects were seen in
shoulder pain at rest and after motion, abduct range of
motion of shoulder, flexibility (sit and reach), chair test,
and 6-minute walk. Neck rotation (left only) was also sig-
nificantly improved. Hand grip strength decreased sig-
nificantly in right hand and decreased to a lesser extent
in the left hand. Isometric shoulder endurance showed
no change.
FIQ
The FIQ is a survey designed specifically to measure the
impact of fibromyalgia on a person's life. After two
months the mean FIQ score had fallen from 51 points to
34 points and decreased further to 28 points at seven
months, (n = 20 at each time point). This is a 33% im-
provement after 2 months, and a 46% improvement after
7 months. The histogram in Figure 1 of the FIQ score
shows a decrease in the scores as the trial progressed.
There was a significant trend (all P < 0.05) for improve-
ment in all scales (see Table 3). There were significant
improvements (P < 0.05 with Bonferroni correction) in
all of the FIQ sub-scales from 0–7 months, and almost all
of the sub-scales from 0–2 months ("work missed" and
"days feeling good" being the exceptions) (see Table 3).
QOL
Quality of life improved during this 7-month trial, with
the composite score rising from an initial 3.9 to 4.7 at 2
months and 4.9 at 7 months (n = 20 each time point, P
for trend < 1E-6), on a scale of 0 to 7, with 7 being a de-
lighted quality of life. There were significant differences
between initial and 2 month scores, and initial and 7
month scores, but not between 2 and 7 month scores (P
< 0.05 with Bonferroni correction). The biggest impact
was seen in active recreation, health, socializing, and
participation in organizations.
SF-36
The SF-36 health survey breaks down health into 8 sub-
headings. These areas are physical functioning, role
physical, bodily pain, general health, vitality, social func-
tioning, role emotional, and mental health (see Table 4).
7 of these 8 areas, bodily pain being the exception,
showed significant improvement (n = 20 each time
point, all P for trend < 0.01). There were significant dif-
ferences for these 7 headings between initial and 2
month scores, except for general health, and also be-
tween initial and 7 month scores, but not between 2 and
7 month scores (P < 0.05 with Bonferroni correction).
Norms for the general population's responses to the SF-
36 questionnaire have been published [20]. Initially, the
mean score for all of the SF-36 scales were significantly
lower than the norms for women ages 45–54. After 7
months of dietary intervention 4 scales were no longer
significantly different from the norms, showing marked
improvement (general health, vitality, role emotional,
mental health) (see Table 4).
Responders versus non-responders
A 10-point improvement in the FIQ score was used to
distinguish responders from non-responders. 19 sub-
jects were classified as responders, 8 as non-responders,
and 3 individuals did not follow through on initial evalu-
ations. Mean FIQ score improvement for responders was
30 points, with a range from 11 to 62 points. Mean FIQ
Figure 1
Histogram of total fibromyalgia impact questionnaire (FIQ)
score. The number of subjects (n = 20 at each time point)
with scores in each range is shown for 0, 2, and 7 months of
dietary intervention. Increasing score denotes a greater nega-
tive impact of FMS on the subject.
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score decreased by 3.6 points for non-responders, with a
range from 3.5 to -14.6 points. The responders' SF-36
scores at 7 months for all scales except bodily pain were
no longer statistically different from norms for women
ages 45–54. Responders to the dietary intervention also
had significant improvements in physical performance
and QOL scores (data not shown), while non-responders
had no significant change in their fibromyalgia status.
Table 2: Physical Evaluation of Subjects.
Initial, n= 18 7 Months, P value,
n = 18 paired
Mean ± SD Mean ± SD t-test
1. Shoulder pain at rest (R) (scale 1–10, 10 worse) 3.9 ± 2.4 1.4 ± 2.0 0.0010
2. Shoulder pain at rest (L) (scale 1–10, 10 worse) 3.4 ± 2.5 1.3 ± 1.9 0.0011
3. Range of active motion of shoulder, flex (R) (degrees) 153 ± 18 161± 14 0.086
4. Range of active motion of shoulder, flex (L) (degrees) 150± 21 159 ± 19 0.114
5. Range of active motion of shoulder, abduct (R)
(degrees) 137 ± 24 157 ± 19 0.0020
6. Range of active motion of shoulder, abduct (L)
(degrees) 139 ± 28 155 ± 28 0.0097
7. Shoulder pain on motion (R) (scale 1–10, 10 worse) 4.1 ± 2.5 2.0 ± 2.7 0.0071
8. Shoulder pain on motion (L) (scale 1–10, 10 worse) 3.7 ± 2.9 1.4 ± 1.9 0.0021
9. Hand-to-neck (R) (0 – 4) 0.22 ± 0.55 0.06 ± 0.24 0.27
10. Hand-to-neck (L) (0 – 4) 0.22 ± 0.55 0.11 ± 0.32 0.50
11. Hand-to-scapula (R) (0 – 4) 0.50 ± 0.62 0.11 ± 0.32 0.0147
12. Hand-to-scapula (L) (0 – 4) 0.44 ± 0.62 0.28 ± 0.75 0.19
13. Isometric shoulder endurance (R) (sec) 69 ± 47 77 ± 50 0.36
14. Isometric shoulder endurance (L) (sec) 73 ± 52 80 ± 57 0.52
15. Neck rotation (R) (degrees) 66 ± 7 70 ± 11 0.13
16. Neck rotation (L) (degrees) 56 ± 12 68 ± 12 0.00003
17. Flexibility (sit-and-reach) (cm) -10.5 ± 9.4 -4.4 ± 6.5 0.0038
18. Chair test (times/minute) 16.4 ± 6.8 19.1 ± 8.1 0.028
19. Hand grip strength (R) 39 ± 17 30 ± 15 0.017
20. Hand grip strength (L) 36 ± 17 30 ± 14 0.078
21. Six-minute walk (m) 465 ± 98 514 ± 112 0.012
Table 3: Fibromyalgia Impact Questionnaire Results. N = 20 at each time point.
Initial 2 months 7 months P for
Mean ± SD Mean ± SD Mean ± SD trend
FIQ score 51.4 ± 14.2a 33.6 ± 15.6b 27.6 ± 19.0b 2.5E-07
Physical impairment 4.8 ± 2.3a 3.6 ± 2.5b 2.7 ± 2.6b 3.5E-04
Feel Good 6.7 ± 3.1a 4.6 ± 3.5a 3.6 ± 3.4b 1.8E-03
Work missed 2.6 ± 3.0a 1.8 ± 2.8a 0.6 ± 1.3b 2.7E-02
Do Job 6.3 ± 2.0a 4.1 ± 2.3b 3.3 ± 2.7b 2.6E-06
Pain 6.6 ± 1.9a 4.5 ± 1.9b 3.6 ± 2.5b 2.7E-06
Fatigue 7.8 ± 2.0a 5.1 ± 2.2b 4.4 ± 2.8b 7.8E-06
Rested 7.8 ± 1.8a 4.7 ± 2.6b 4.1± 2.9b 1.4E-06
Stiffness 7.1 ± 2.1a 4.8 ± 2.2b 3.8 ± 2.3b 1.4E-07
Anxiety 5.7 ± 2.7a 3.2 ± 2.0b 3.0 ± 2.3b 6.5E-05
Depression 5.0 ± 3.0a 3.1 ± 2.2b 2.4 ± 2.5b 1.6E-04
Numbers with different superscripts are statistically different (P < 0.05 with Bonferroni adjustment).BMC Complementary and Alternative Medicine 2001, 1:7 http://www.biomedcentral.com/1472-6882/1/7
Discussion
The connection between dietary and lifestyle habits with
chronic diseases has become increasingly strong in the
past several years. Most of the research has been towards
the prevention of chronic disease rather than toward its
treatment.
The natural course of fibromyalgia shows that symptoms
are generally the same over at least 7 years [3]. A stable,
sharp reduction in symptoms in seven months, as we
have reported here, is a definite alteration of the natural
history of fibromyalgia.
Group treatment of fibromyalgia patients using a multi-
faceted approach resulted in a 25% improvement in
overall FIQ score and a 5.2 cm increase in sit and reach
flexibility [21]. This study resulted in even greater im-
provements with a 46% improvement in overall FIQ
score and a 6.1 cm increase in sit-and-reach flexibility. A
six-week exercise and education program produced a to-
tal drop in 8 FIQ subscales of 2.4 points [22]; these same
subscales in this study decreased by 23.9 points after the
dietary intervention reported here. This comparison
shows that education and exercise are not as an effective
intervention as this dietary intervention.
As mentioned, vegetarian dietary intervention of fibro-
myalgia has been tested by two investigators. In a small
study of 10 patients, Hostmark et al [14] found a 3-week
vegetarian diet produced an improvement in subjective
well-being. Increase in well-being, as seen in the im-
provement in quality of life, FIQ, and SF-36 scores, was
also seen in our study. In a recent study Kaartinen et al
[15] used a strict "living-foods" pure vegetarian diet in 3-
month non-randomized, controlled study of FMS. Inves-
tigators saw significant improvements in pain scores and
significantly less morning stiffness, similar to our re-
sults. Apparently the diet was difficult to implement and
no subjects continued with the "living-foods" diet. Symp-
toms returned upon reverting back to a more standard
diet, showing even more clearly the association of diet
and FMS. Maintenance of diets requiring more food
preparation time and uncommon foods is difficult. Since
the diet used here is mainly based on common foods the
long-term adherence to the program is likely to be high-
er. Subjects learned which foods caused them the most
symptoms so that they avoided these foods on a long-
term basis.
Initial scores using the SF-36 health survey, compared to
population norms, were very similar to those reported
elsewhere [7]. This indicates that our fibromyalgia sub-
jects were very similar to other surveyed groups in terms
of their health status. Initial FIQ scores are also in line
with other studies [21]. After 7 months, the 19 subjects
that responded to the diet were no longer statistically dif-
ferent from the general population of women aged 45–
54, except for bodily pain. This indicates a remarkable
recovery of function in a short period of time.
Self-reported pain was significantly reduced as meas-
ured by the FIQ and by the physical performance meas-
urements, but not as measured by the SF-36
questionnaire. Both the FIQ and physical performance
measure used a visual analog scale from 0–10 to measure
pain, whereas the SF-36 only used 2 questions with a to-
tal range of 10 points to measure bodily pain. This may
have made the SF-36 a less sensitive measure of bodily
pain than the other two measures.
It was unclear whether or not closer adherence to the diet
by the non-responders would have resulted in better suc-
cess. Without rapid improvements a few subjects lost
motivation and adhered less to the diet, while others saw
Table 4: SF-36 Results. Norm data is for women aged 45–54 [20]. N = 20 at each time point.
SF-36 Scale Norm Initial 2 months 7 months P for
Mean ± SD Mean ± SD Mean ± SD Mean ± SD trend
Physical Functioning 82.9 ± 21.7a 36.3 ± 24.3b 55.0 ± 23.4c 60.3 ± 26.7c 1.7E-06
Role Physical 79.9 ± 35.4a 6.3 ± 11.1b 31.3 ± 42.0c 36.3 ± 41.7c 0.0074
Bodily Pain 72.1 ± 23.3a 32.6 ± 20.2b 40.1 ± 23.2c 48.5 ± 28.8b 0.071
General Health 70.5 ± 20.6a 44.1 ± 21.6b 52.0 ± 
23.3b,c
61.2 ± 24.8a,c 2.3E-05
Vitality 60.6 ± 21.3a 18.0 ± 14.4b 41.8 ± 27.4c 48.0 ± 28.9a,c 2.4E-05
Social Functioning 82.7 ± 20.8a 40.0 ± 26.5b 60.6 ± 22.3c 66.3 ± 25.7c 6.4E-05
Role Emotional 81.9 ± 33.3a 25.0 ± 26.5b 61.7 ± 22.3a 75.0 ± 25.7a 1.6E-04
Mental Health 74.4 ± 18.1a 57.2 ± 23.1b 73.4 ± 18.3a 77.0 ± 15.3a 4.7E-04
Numbers with different superscripts are statistically different (P < 0.05 with Bonferroni adjustment).BMC Complementary and Alternative Medicine 2001, 1:7 http://www.biomedcentral.com/1472-6882/1/7
positive results within a couple of weeks, thus encourag-
ing them to continue faithfully. The basis for not re-
sponding to the diet may have been physiological rather
than motivational. Further research will help answer this
question.
What caused the significant improvements seen in this
intervention study? There is likely a synergy of both
physiological and psychological factors. The change in
diet gave the subjects motivation to take control of their
symptoms, to overcome their disabilities and inactivity.
People that believed that a change in their diet would im-
prove their symptoms were attracted to this study. The
effect of expecting a positive result was not measured,
but it certainly was beneficial to the subjects.
Some aspects of the new diet also improve fatigue and
sleep patterns, so that overwhelming fatigue did not
squelch subjects' newfound motivation. Subjects could
begin an upward cycle out of their FMS symptoms, rath-
er continuing the downward trend toward further disa-
bility, chronic pain, and depression.
Intakes of fats, protein, fiber, several vitamins, including
the antioxidants vitamin C, vitamin E, and beta-caro-
tene, and minerals (especially magnesium, potassium,
and zinc) are significantly different from the general
population's dietary intake (see Table 1), so it is difficult
to single out which factors were most important in pro-
ducing the dramatic improvements seen in this study.
The improvement is likely the synergistic result of sever-
al factors. It is unlikely that a single factor or a dietary
supplement will be able to reproduce the results generat-
ed by an overall dietary change.
Though the FFQ used in this study has not been validat-
ed rigorously, a comparison to 7-day semi-quantitative
dietary intake of people following the same Hallelujah
Diet (unpublished data) showed that, on an energy basis,
the only significant differences between nutrient intakes
reported here and in that survey were for fiber and vita-
min A. So, it appears that the FFQ captured nutrient in-
takes satisfactorily.
Our study had several limitations. First, because all of
the subjects did not currently meet the diagnosis criteria
of FMS, the results cannot be compared directly with
other studies. It's possible, but cannot be proven here,
that greater improvement would have been seen with
people who were experiencing more pain. It's also possi-
ble that subjects with less severe pain were able to im-
prove quicker. Equal percentages of subjects with more
than 11 painful tender points were found among re-
sponders and non-responders.
Second, as an unblinded observational study there was
no direct comparison with a control group. Many histor-
ical controls were available and the natural, chronic
course of FMS is well described. However, the results
would certainly be stronger if an active control group was
included. Another limitation was the size of the treat-
ment group. Though the subjects here seemed to be rep-
resentative of people with FMS, it is not certain that the
same results would be seen in a large study. These results
should be reproduced and extended in a larger, control-
led trial.
Conclusions
In summary, a diet intervention using a mostly raw, pure
vegetarian diet produced dramatic improvements in
FMS symptoms. 19 of 30 participants responded very fa-
vorably to the intervention, seeing marked improvement
in all FMS symptoms. This dietary intervention shows
that many fibromyalgia subjects can be helped even
without understanding the full cause of their symptoms.
Further controlled studies are needed to reproduce and
extend the results obtained here to see if this dietary in-
tervention is a viable adjunctive therapy for managing fi-
bromyalgia in a clinical setting.
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